Skip to main content

Table 1 Demographic, anthropometric, clinical, and pulmonary function data in control subjects and patients with COPD and ILD

From: Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation

 

COPD (n = 18)

ILD (n = 28)

Control (n = 10)

Age, years

58 ± 1*

58 ± 2*

51 ± 2

Sex, M/F

17/1*

18/10*§

4/6

BMI, kg/m2

25.0 ± 1.4

26.3 ± 0.8

23.6 ± 1.2

FC II/III/IV, %

0/78/22

14/79/7

 

6MWT, meters

300 ± 22

315 ± 15

 

FVC, L

1.8 ± 0.2

1.9 ± 0.14

 

FVC, % predicted

44 ± 3

50 ± 3

 

FEV1, L

0.77 ± 0.08

1.56 ± 0.13§

 

FEV1, % predicted

24 ± 2

58 ± 3§

 

FEV1/FVC

0.42 ± 0.03

0.82 ± 0.03§

 

DLCO, % predicted

33 ± 5

27 ± 2§

 

FVC%/DLCO%

1.5 ± 1.0

2.6 ± 0.3§

 

PaO2, mm Hg

64 ± 2.3

62 ± 2.4

 

PaCO2, mm Hg

50 ± 2.3

40 ± 1.4§

 
  1. Data are mean ± SEM
  2. Abbreviations: BMI body mass index, 6MWT 6-min walking test, DLCO diffusion capacity of the lung for carbon monoxide, FC functional class, FEV1 forced expiratory volume in one second, FVC forced vital capacity, PaO 2 and PaCO 2 partial arterial pressure of oxygen and dioxide of carbon, respectively
  3. *p < 0.05 vs. Control; §p < 0.05 vs. COPD
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us